These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 8040256

  • 1. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
    Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R.
    J Clin Invest; 1994 Jul; 94(1):155-64. PubMed ID: 8040256
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
    Regnström J, Walldius G, Nilsson S, Elinder LS, Johansson J, Mölgaard J, Holme I, Olsson AG, Nilsson J.
    Atherosclerosis; 1996 Sep 06; 125(2):217-29. PubMed ID: 8842353
    [Abstract] [Full Text] [Related]

  • 4. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse.
    Crawford RS, Kirk EA, Rosenfeld ME, LeBoeuf RC, Chait A.
    Arterioscler Thromb Vasc Biol; 1998 Sep 06; 18(9):1506-13. PubMed ID: 9743241
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits.
    Fruebis J, Silvestre M, Shelton D, Napoli C, Palinski W.
    J Lipid Res; 1999 Nov 06; 40(11):1958-66. PubMed ID: 10552999
    [Abstract] [Full Text] [Related]

  • 6. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
    Keaney JF, Xu A, Cunningham D, Jackson T, Frei B, Vita JA.
    J Clin Invest; 1995 Jun 06; 95(6):2520-9. PubMed ID: 7769097
    [Abstract] [Full Text] [Related]

  • 7. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK.
    Kidney Int; 1997 Apr 06; 51(4):1151-9. PubMed ID: 9083281
    [Abstract] [Full Text] [Related]

  • 8. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.
    Shaish A, Daugherty A, O'Sullivan F, Schonfeld G, Heinecke JW.
    J Clin Invest; 1995 Oct 06; 96(4):2075-82. PubMed ID: 7560102
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.
    Fruebis J, Steinberg D, Dresel HA, Carew TE.
    J Clin Invest; 1994 Jul 06; 94(1):392-8. PubMed ID: 8040279
    [Abstract] [Full Text] [Related]

  • 10. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
    Wu YJ, Hong CY, Lin SJ, Wu P, Shiao MS.
    Arterioscler Thromb Vasc Biol; 1998 Mar 06; 18(3):481-6. PubMed ID: 9514418
    [Abstract] [Full Text] [Related]

  • 11. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE, Schwenke DC, Steinberg D.
    Proc Natl Acad Sci U S A; 1987 Nov 06; 84(21):7725-9. PubMed ID: 3478721
    [Abstract] [Full Text] [Related]

  • 12. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA, Demacker PN, Stalenhoef AF.
    Arterioscler Thromb; 1994 Aug 06; 14(8):1386-91. PubMed ID: 8049202
    [Abstract] [Full Text] [Related]

  • 13. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL, Mogelesky TC, Sharif R, Sawyer WK, Jeune M, Hu CW, Leonards KS, Prescott MF.
    Atherosclerosis; 1999 Jun 06; 144(2):343-55. PubMed ID: 10407495
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis.
    Morel DW, de la Llera-Moya M, Friday KE.
    J Nutr; 1994 Nov 06; 124(11):2123-30. PubMed ID: 7965195
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
    Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W.
    J Clin Invest; 1997 Dec 01; 100(11):2680-90. PubMed ID: 9389731
    [Abstract] [Full Text] [Related]

  • 18. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.
    Daugherty A, Zweifel BS, Schonfeld G.
    Br J Pharmacol; 1989 Oct 01; 98(2):612-8. PubMed ID: 2819336
    [Abstract] [Full Text] [Related]

  • 19. Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters.
    Parker RA, Sabrah T, Cap M, Gill BT.
    Arterioscler Thromb Vasc Biol; 1995 Mar 01; 15(3):349-58. PubMed ID: 7749845
    [Abstract] [Full Text] [Related]

  • 20. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
    O'Brien K, Nagano Y, Gown A, Kita T, Chait A.
    Arterioscler Thromb; 1991 Mar 01; 11(3):751-9. PubMed ID: 2029510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.